Ventas (VTR)
NYSE Market Closed
Ventas, Inc. is a real estate investment trust focused on healthcare and senior living properties. The company owns a large, diversified portfolio that spans senior housing communities, medical office buildings, hospitals, life science facilities, and skilled nursing or post-acute care assets. Its properties are primarily located in the United States, with additional exposure to Canada and the United Kingdom.
The company’s strategy is built around long-term demographic and healthcare trends. An aging population supports demand for senior housing and care-related real estate, while medical office and life science properties benefit from the continued importance of outpatient care, research, and healthcare delivery infrastructure. Ventas invests in markets with established healthcare systems and operators, giving it exposure to both needs-based real estate and more specialized medical property categories.
Ventas operates through a mix of business models. Some senior housing assets are managed through operating relationships, allowing the company to participate more directly in property-level performance. Other assets are leased to healthcare providers or operators under longer-term agreements, which can provide more predictable rental income. The company also holds mortgages and other loans, although these account for only a small portion of overall net operating income.
As a REIT, Ventas is typically evaluated on portfolio quality, occupancy trends, operator performance, funding costs, and its ability to grow cash flow while maintaining a sustainable dividend. Its scale across nearly 1,400 in-place properties gives it broad exposure to healthcare real estate, while its diversification across property types helps reduce reliance on any single segment of the healthcare system.
Last updated
- Market Cap
- 40.37B
- P/E
- 155.02
- P/FCF
- 47.88
- P/S
- 6.6
- Enterprise Value
- 52.71B
- Sector
- Real Estate
- Industry
- Health Care REITs
- Address
- 300 N LASALLE STREET, CHICAGO, IL, 60654
No recent news is linked to this listing.
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 40.37B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 52.71B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 155.02
- P/B
P/B ratio compares a company's share price to its book value per share.
- 3.08
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 6.6
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 23.26
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 8.62
- EPS
- 0.54
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.22%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 47.88
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 23.47
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 843.21M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 1.98%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 0.94%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.95
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.13
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.13
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.12
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 4.24M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 83.04
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.65B | 1.57B | 1.48B | 1.41B | 1.35B |
| Gross profit | 652.91M | 636.6M | 610.89M | 585.36M | 571.11M |
| Operating income | 189.06M | 247.25M | 192.97M | 188.53M | 187.22M |
| EBITDA | 583.4M | 601.58M | 552.39M | 528.21M | 512.53M |
| Net income | 55.91M | 70.2M | 66.05M | 68.26M | 46.87M |
| Basic EPS | 0.12 | 0.15 | 0.14 | 0.15 | 0.11 |
| Diluted EPS | 0.11 | 0.14 | 0.14 | 0.15 | 0.1 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 27.69B | 27.59B | 26.93B | 26.47B | 26.03B |
| Total liabilities | 14.11B | 14.63B | 14.15B | 14.55B | 14.17B |
| Total equity | 13.18B | 12.59B | 12.42B | 11.59B | 11.53B |
| Cash & equivalents | 183.61M | 741.07M | 188.62M | 614.2M | 182.34M |
| Current assets | 197.14M | 784.06M | 258.7M | 664.29M | 182.34M |
| Current liabilities | 1.56B | 1.59B | 14.13B | 14.54B | 14.05B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 394.61M | 471.66M | 378.58M | 475.34M | 321.14M |
| Investing cash flow | -1.07B | -428.72M | -1.18B | -204.42M | -883.74M |
| Financing cash flow | 89.96M | 499.86M | 366.07M | 156.97M | -149.14M |
| Change in cash | -583.94M | 542.8M | -432.88M | 427.88M | -711.74M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Ventas, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| form 4 | Form 4 — EMBLER MICHAEL J | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 13F-HR — Ventas, Inc. | View Filing | |
| edgar index | 424B5 — Ventas, Inc. | View Filing | |
| edgar index | 8-K — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 144 — Ventas, Inc. | View Filing | |
| form 4 | Form 4 — RAKOWICH WALTER C | View Filing | |
| form 4 | Form 4 — BIGMAN THEODORE | View Filing | |
| form 4 | Form 4 — RAKOWICH WALTER C | View Filing | |
| form 4 | Form 4 — LUSTIG MATTHEW J | View Filing | |
| form 4 | Form 4 — EMBLER MICHAEL J | View Filing | |
| form 4 | Form 4 — NADER MARGUERITE M | View Filing | |
| form 4 | Form 4 — Roy Sumit | View Filing | |
| form 4 | Form 4 — Nolan Sean P. | View Filing | |
| form 4 | Form 4 — Barnes Melody C | View Filing | |
| form 4 | Form 4 — Martino Roxanne M | View Filing | |
| form 4 | Form 4 — Smith Maurice S | View Filing | |
| form 4 | Form 4 — Rodriguez Joe Vasquez Jr. | View Filing | |
| edgar index | SCHEDULE 13G/A — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Ventas, Inc. | View Filing | |
| form 4 | Form 4 — Bulgarelli Peter J. | View Filing | |
| form 4 | Form 4 — Bulgarelli Peter J. | View Filing | |
| form 4 | Form 4 — Bulgarelli Peter J. | View Filing | |
| edgar index | SCHEDULE 13G — Ventas, Inc. | View Filing | |
| edgar index | 10-Q — Ventas, Inc. | View Filing | |
| edgar index | 8-K — Ventas, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| form 4 | Form 4 — LUSTIG MATTHEW J | View Filing | |
| form 4 | Form 4 — LUSTIG MATTHEW J | View Filing | |
| form 4 | Form 4 — EMBLER MICHAEL J | View Filing | |
| form 4 | Form 4 — NADER MARGUERITE M | View Filing | |
| form 4 | Form 4 — Roy Sumit | View Filing | |
| form 4 | Form 4 — Roy Sumit | View Filing | |
| form 4 | Form 4 — Barnes Melody C | View Filing | |
| form 4 | Form 4 — Martino Roxanne M | View Filing | |
| form 4 | Form 4 — Smith Maurice S | View Filing | |
| form 4 | Form 4 — Smith Maurice S | View Filing | |
| form 4 | Form 4 — Rodriguez Joe Vasquez Jr. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | 4 — Ventas, Inc. | View Filing | |
| edgar index | DEF 14A — Ventas, Inc. | View Filing | |
| edgar index | DEFA14A — Ventas, Inc. | View Filing | |
| edgar index | ARS — Ventas, Inc. | View Filing | |
| form 4 | Form 4 — LUSTIG MATTHEW J | View Filing | |
| form 4 | Form 4 — Roy Sumit | View Filing | |
| form 4 | Form 4 — Martino Roxanne M | View Filing | |
| form 4 | Form 4 — Smith Maurice S | View Filing | |
| edgar index | SCHEDULE 13G/A — Ventas, Inc. | View Filing | |
| edgar index | 144 — Ventas, Inc. | View Filing | |
| edgar index | 8-K — Ventas, Inc. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free